PureTech and its programs have attracted over $450M in funding and have active strategic partnerships with some of the most forward-thinking health and technology companies in the world. Our robust pipeline including 20 clinical studies – is focused on addressing some of society’s largest healthcare needs in multi-billion-dollar market segments, including those at the intersection of the brain, gut and immune system.
“PureTech has the scientific creativity to really go for the big ideas that can be game changers. The team dreams up technologies and then makes them happen”
- Dr. Robert Langer, PureTech Co-Founder & Non-Executive Director